Health ❯ Healthcare ❯ Pharmaceuticals

Drug Safety

Mifepristone Medication Recall Product Recalls Product Recall Recalls Counterfeit Medications Contaminated Drugs Adverse Effects Quality Control Adverse Reactions

Xenon Submits NDA for Epilepsy Drug as Psychiatric Trials Pause After Safety Signals

The enrollment halt raises doubt that dosing changes can cut neuropsychiatric side effects without reducing efficacy.

Houston Compounder Recalls Injectable Wellness Products Over Endotoxin Contamination

Company Recalls Three Lots of Multi‑Dose Epinephrine Vials Over Contamination Concerns

Novartis Pauses CAR‑T Autoimmune Trials After Three Deaths

Vitruvias Recalls Lot of Thyroid Tablets Over 'Superpotent' Test Results

France Withdraws Tavneos After EU Finds Unfavourable Safety Profile

AstraZeneca Stops Phase III Volrustomig Lung Cancer Trial

Sub‑Five‑Second Hose Disconnection at Ramallo Plant Tied to Contaminated Fentanyl and 90 Deaths

Former ANMAT Leaders Freed After Paying Large Property Bonds as Fentanyl Inquiry Deepens

Mounjaro Study Finds Lower Heart‑Attack Risk as UK Safety Reports Rise

FDA Advisory Panel Recommends Six Peptides for Pharmacy Compounding

ANMAT Moves Ten Medicines to Over-the-Counter Sale

Major Rugby Recalls 12 Batches of Levothyroxine Nationwide

Anvisa Says Retatrutida Is Unapproved as Illegal Versions Spread

TGA Warns Popular GLP‑1 Drugs May Be Linked to Rare Optic‑Nerve Disorder

Cofepris Warns of Falsified Bayer Products and Stolen Medikinet

Manufacturer Recalls Generic Zyrtec Over Possible Ranitidine Contamination

FDA Grants Priority Review to Pfizer’s Talzenna Plus Xtandi for HRR-Altered mCSPC

Uttarakhand Raid Nets Large Cache of Suspected Counterfeit Medicines

Anvisa Seizes Falsified Mounjaro Lots and Bans Unregistered Supplements